Select a person from the recent news from the list below,
or use Advanced Search to find older articles

(Enter last name only) go
CLOSE THIS PANEL
People from the recent news.
CLOSE THIS PANEL

Select a company in the recent news from the list below,
or use Advanced Search to find older articles

go
go
CLOSE THIS PANEL
Companies from the recent news.
CLOSE THIS PANEL

Send to a friend.


Separate email addresses with a comma ( , )




NEWS

7:09 AM, 16 Jul 2008

Patent bid sparks cancer-test price fears

Abstracted from The Australian


A decision by Genetic Technologies could make breast cancer examinations more expensive, according to Cancer Australia. Genetic holds the Australian and New Zealand patent licences for a test that detects mutations in breast cancer genes, and recently announced plans to use its patent rights to conduct all future testing itself. Women with the defective gene have an 85 per cent change of contracting the disease, against a community-wide average of around nine per cent. Cancer Council Australia CEO, Ian Olver, said allowing genes to be patented could be problematic in the long term and could compromise the Human Genome Project

Distributed by News Bites. © Lexis-Nexis


Share This Story
Digg This Add to Propeller Facebook Add To Reddit Add To Del.icio.us